Scientists from the U.S. Army Medical Research Institute of Infectious Diseases were recognized for their work on ZMapp, a therapeutic monoclonal antibody "cocktail" designed to treat Ebola virus infection, at the Federal Laboratory Consortium for Technology Transfer national meeting April 27 in Chicago. Pictured from L to R are Paul Zielinski, FLC Chair; Barry Datlof, USAMRMC Technology Transfer; Mark Dertzbaugh, USAMRIID Business Plans & Programs; Tylar Temple, ASA(ALT); and Mark Reeves, FLC Vice Chair. (FLC courtesy photo)